Skip to content

Clinical trials

Observational Cardiotoxicity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Phase: Observational Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20085
20091
20102
20114
20132
20148
20155
20164
20175
20183
201910
202012
202117
20228
20237
20247
20259
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Unknown status33
Recruiting20
Active, not recruiting7
Not yet recruiting7
Terminated4
Enrolling by invitation3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abramson Cancer Center at Penn Medicine8
Groupe Hospitalier Pitie-Salpetriere5
Assistance Publique - Hôpitaux de Paris3
Istanbul University3
Peking University Third Hospital3
Radboud University Medical Center3
AHS Cancer Control Alberta2
Ain Shams University2
Memorial Sloan Kettering Cancer Center2
Peking University Cancer Hospital & Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity118
Breast Neoplasms35
Heart Failure21
Neoplasms21
Cardiovascular Diseases9
Lymphoma7
Cardiomyopathies6
Heart Diseases6
Lung Neoplasms6
Carcinoma, Non-Small-Cell Lung5

Trials

Showing 76 to 100 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.